Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-15-065709
Filing Date
2015-02-26
Accepted
2015-02-26 16:21:27
Documents
14
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d856934d10k.htm 10-K 1262687
2 EX-10.19 d856934dex1019.htm EX-10.19 61304
3 EX-21.1 d856934dex211.htm EX-21.1 4808
4 EX-23.1 d856934dex231.htm EX-23.1 1394
5 EX-31.1 d856934dex311.htm EX-31.1 7485
6 EX-31.2 d856934dex312.htm EX-31.2 7389
7 EX-32.1 d856934dex321.htm EX-32.1 4031
14 GRAPHIC g856934g69h30.jpg GRAPHIC 105053
  Complete submission text file 0001193125-15-065709.txt   9117776

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT geva-20141231.xml EX-101.INS 1406710
9 XBRL TAXONOMY EXTENSION SCHEMA geva-20141231.xsd EX-101.SCH 61611
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE geva-20141231_cal.xml EX-101.CAL 92396
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE geva-20141231_def.xml EX-101.DEF 202855
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE geva-20141231_lab.xml EX-101.LAB 549266
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE geva-20141231_pre.xml EX-101.PRE 377557
Mailing Address 33 HAYDEN AVE. LEXINGTON MA 02421
Business Address 33 HAYDEN AVE. LEXINGTON MA 02421 (781) 357-9900
SYNAGEVA BIOPHARMA CORP (Filer) CIK: 0000911326 (see all company filings)

EIN.: 561808663 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-23155 | Film No.: 15652819
SIC: 2836 Biological Products, (No Diagnostic Substances)